There was no significant difference in the SIRPα expression levels on CD3+ T cells, CD19+ B cells, CD56+ NK cells or CD14+ monocytes between PBC patients and the Control group (P>0.05) (Figures 3E–H). This evidence concerns the gene CD19 and primary biliary cholangitis.